全文获取类型
收费全文 | 949篇 |
免费 | 42篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 29篇 |
妇产科学 | 30篇 |
基础医学 | 68篇 |
口腔科学 | 20篇 |
临床医学 | 95篇 |
内科学 | 206篇 |
皮肤病学 | 26篇 |
神经病学 | 74篇 |
特种医学 | 37篇 |
外科学 | 81篇 |
综合类 | 7篇 |
预防医学 | 134篇 |
眼科学 | 11篇 |
药学 | 35篇 |
中国医学 | 4篇 |
肿瘤学 | 131篇 |
出版年
2023年 | 5篇 |
2022年 | 6篇 |
2021年 | 25篇 |
2020年 | 13篇 |
2019年 | 30篇 |
2018年 | 26篇 |
2017年 | 10篇 |
2016年 | 13篇 |
2015年 | 15篇 |
2014年 | 15篇 |
2013年 | 48篇 |
2012年 | 65篇 |
2011年 | 47篇 |
2010年 | 12篇 |
2009年 | 26篇 |
2008年 | 58篇 |
2007年 | 50篇 |
2006年 | 62篇 |
2005年 | 62篇 |
2004年 | 53篇 |
2003年 | 35篇 |
2002年 | 48篇 |
2001年 | 35篇 |
2000年 | 31篇 |
1999年 | 23篇 |
1998年 | 10篇 |
1997年 | 10篇 |
1996年 | 6篇 |
1995年 | 8篇 |
1993年 | 7篇 |
1992年 | 10篇 |
1991年 | 14篇 |
1990年 | 13篇 |
1989年 | 11篇 |
1988年 | 9篇 |
1987年 | 13篇 |
1986年 | 6篇 |
1985年 | 4篇 |
1984年 | 4篇 |
1980年 | 4篇 |
1979年 | 6篇 |
1977年 | 4篇 |
1976年 | 4篇 |
1975年 | 3篇 |
1973年 | 3篇 |
1971年 | 4篇 |
1968年 | 2篇 |
1967年 | 2篇 |
1966年 | 3篇 |
1965年 | 2篇 |
排序方式: 共有992条查询结果,搜索用时 15 毫秒
1.
2.
3.
M A Rubio I Torres-Aleman J R Calle J A Cabranes A V Schally A L Charro 《The Journal of clinical endocrinology and metabolism》1987,65(2):368-369
The effect of a potent agonistic analog of LHRH, D-Trp6-LHRH, on hyperprolactinemia induced by sulpiride was studied in normal men. Six men received sulpiride (100 mg, twice daily, orally) for 44 days. D-Trp6-LHRH was given sc during the last 2 weeks of sulpiride administration; the dose was 500 micrograms on the first day and 100 micrograms daily for the subsequent 14 days. All men had high serum PRL levels before D-Trp6-LHRH administration (mean +/- SEM, 56 +/- 9 ng/mL), which decreased significantly after the first dose of the analog (45 +/- 5 ng/mL; P = 0.031) and also after 15 days of analog administration (41 +/- 6 ng/mL; P = 0.016). These data demonstrate that administration of LHRH agonist can inhibit the hyperprolactinemic effect of sulpiride, suggesting a direct action of the analog on the pituitary gland to modulate PRL secretion. 相似文献
4.
Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort. 总被引:2,自引:0,他引:2
Eric J Jacobs Carmen Rodriguez Elizabeth B Bain Yiting Wang Michael J Thun Eugenia E Calle 《Cancer epidemiology, biomarkers & prevention》2007,16(11):2213-2217
BACKGROUND: 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors, commonly known as statins, account for the great majority of cholesterol-lowering drug use in the United States. Long-duration statin use was associated with substantially reduced risk of advanced prostate cancer in a recent large prospective study. METHODS: We examined the association between use of cholesterol-lowering drugs and prostate cancer incidence by disease stage and grade among 55,454 men in the Cancer Prevention Study II Nutrition Cohort. Proportional hazards modeling was used to calculate RRs. RESULTS: During follow-up from 1997 to 2003, we identified 3,413 cases of incident prostate cancer, including 317 cases of advanced prostate cancer. After adjustment for age, history of prostate-specific antigen testing, and other potential prostate cancer risk factors, current use of cholesterol-lowering drugs for 5 or more years was not associated with overall prostate cancer incidence (multivariate adjusted rate ratio, 1.06; 95% confidence interval, 0.93-1.20), but was associated with a marginally statistically significant reduction in risk of advanced prostate cancer (rate ratio, 0.60; 95% confidence interval, 0.36-1.00). CONCLUSION: These results provide some support for the hypothesis that long-term statin use is associated with reduced risk of advanced prostate cancer. 相似文献
5.
Identifying the special needs of children with Type 1 diabetes in the school setting. An overview of parents' perceptions. 总被引:1,自引:0,他引:1
AIMS: The aims of this observational study were to identify the special needs of children with Type 1 diabetes in schools from the parents' point of view and the difficulties experienced with full integration, and to define a series of interventions which may improve the situation. METHODS: Parents of children aged 3-18 years with Type 1 diabetes were eligible. Those who agreed to participate completed a self-reporting questionnaire which determined the effects of the disease on children, parents and school personnel, and addressed aspects including children's integration, glycaemic control, insulin administration, meals, sports, trips and attitudes of teachers and school colleagues to their disease. RESULTS: A total of 499 questionnaires were completed and validated. Median age of children was 11.5 years (95% CI 7.8-15.2). Only 34% of parents believed that teachers could recognize the symptoms of a mild hypoglycaemic episode. Seventeen per cent of parents experienced problems at their schools when they informed staff about their children's disease, 5% were finally not accepted and 8% were forced to change school. In some cases, they had to modify glucose monitoring (9%) and treatment administration (16%) because of a lack of cooperation from the school. CONCLUSIONS: Training sessions on Type 1 diabetes, an increase in the number of nurses, better availability of resources from diabetic associations to schools and improved communication between school personnel and parents were identified as key factors that may improve the full integration of the diabetic child in this setting. 相似文献
6.
Patricio López-Jaramillo Director Marcelo Narváez Professor rés Calle Professor José Rivera Consultant Patricio Jácome Registrar César Ruano Professor Eduardo Nava Consultant 《BJOG : an international journal of obstetrics and gynaecology》1996,103(1):33-38
Objective To elucidate the role of the L-arginine: nitric oxide pathway in pregnancy and pre-eclampsia.
Participants Pregnant women (nulliparous, age < 25 years). Normotensive pregnancy ( n = 22 ) was defined when blood pressure remained at levels of < 120/80 mmHg and there was no proteinuria. Women with pre-eclampsia ( n = 22 ) had blood pressure measurements of > 140/90 mmHg and proteinuria of > 300 mg/l. Nonpregnant normotensive women ( n = 22 ) were studied as controls.
Study Design Blood samples were taken for measurements of ionised calcium, atrial natriuretic factor, cyclic guanosine 3'5'monophophate (GMP), arginine and asymmetric dimethylarginine. Urine samples were collected for determination of cyclic GMP excretion. Cyclic GMP concentrations were also determined in 12 women with severe pre-eclampsia before and after treatment with hydralazine.
Results L-arginine, asymmetric dimethylarginine and atrial natriuretic factor were not different in any group. Cyclic GMP concentrations in plasma [0.94 (SD 0.23) nM] as well as in urine [50.1 (SD15.7)μM] were increased significantly ( P < 0.05 ) in normal pregnancy compared to nonpregnant controls [plasma mean 0.46 (SD 0.12) nM and urine mean 18.4 (SD 10.3) μM], but not in the pre-eclampsia group [plasma mean 0.48 (SD 0.10) nM and urine mean 24.1 (SD 14.5) μM]. Concentrations of cyclic GMP in plasma and urine increased significantly ( P < 0.05 ) in women treated with hydralazine.
Conclusions The differences in cyclic GMP concentrations may reflect differences in nitric oxide production. Hydralazine increases cyclic GMP concentrations in severely pre-eclamptic women. This action could explain the antihypertensive effect of hydralazine. 相似文献
Participants Pregnant women (nulliparous, age < 25 years). Normotensive pregnancy ( n = 22 ) was defined when blood pressure remained at levels of < 120/80 mmHg and there was no proteinuria. Women with pre-eclampsia ( n = 22 ) had blood pressure measurements of > 140/90 mmHg and proteinuria of > 300 mg/l. Nonpregnant normotensive women ( n = 22 ) were studied as controls.
Study Design Blood samples were taken for measurements of ionised calcium, atrial natriuretic factor, cyclic guanosine 3'5'monophophate (GMP), arginine and asymmetric dimethylarginine. Urine samples were collected for determination of cyclic GMP excretion. Cyclic GMP concentrations were also determined in 12 women with severe pre-eclampsia before and after treatment with hydralazine.
Results L-arginine, asymmetric dimethylarginine and atrial natriuretic factor were not different in any group. Cyclic GMP concentrations in plasma [0.94 (SD 0.23) nM] as well as in urine [50.1 (SD15.7)μM] were increased significantly ( P < 0.05 ) in normal pregnancy compared to nonpregnant controls [plasma mean 0.46 (SD 0.12) nM and urine mean 18.4 (SD 10.3) μM], but not in the pre-eclampsia group [plasma mean 0.48 (SD 0.10) nM and urine mean 24.1 (SD 14.5) μM]. Concentrations of cyclic GMP in plasma and urine increased significantly ( P < 0.05 ) in women treated with hydralazine.
Conclusions The differences in cyclic GMP concentrations may reflect differences in nitric oxide production. Hydralazine increases cyclic GMP concentrations in severely pre-eclamptic women. This action could explain the antihypertensive effect of hydralazine. 相似文献
7.
8.
ABPA mimicking bronchogenic cancer 总被引:1,自引:0,他引:1
9.
D Y Munesinghe P Clavijo M C Calle R S Nussenzweig E Nardin 《European journal of immunology》1991,21(12):3015-3020
The immunogenicity of multiple antigen peptides (MAP) constructs containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite (CS) protein was examined in vitro, using a human T cell clone, and in vivo, using four different strains of mice. All the MAP constructs that contained the T cell epitope, (DPNANPNVDPNANPNV), stimulated proliferation and interferon-gamma production by a human T cell clone specific for this epitope which is located in the 5' end of the repeat region of the P. falciparum CS protein. These human T cells did not recognize MAP that contained only the B cell epitope, (NANP)3, which is located in the 3' repeat region. Optimal antibody responses were obtained in mice immunized with MAP containing four copies of tandemly arranged T and B cell epitopes, (TB)4. The murine immune response to the MAP constructs was genetically restricted. Mice of a high responder strain, C57BL, recognized both the 5' and 3' repeat sequences in the MAP as T, as well as B, cell epitopes and developed very high anti-MAP and anti-sporozoite antibody titers. A/J and C3H mice, which were intermediate responders, developed lower antibody titers which varied according to the orientation of the T vs. the B cell epitopes within the MAP constructs. BALB/c mice were nonresponders and did not develop antibodies following immunization with any of the MAP constructs containing the 5' and 3' repeats of the P. falciparum CS protein. 相似文献
10.